AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of News Paper clippings where Unaudited Financial Results for Q3FY24 are published12-02-2024
12-02-2024
Aurobindo Pharma surges 3% as investors cheer strong Q3 earnings
Aurobindo Pharma's Q3 net profit soared 91 percent on year and revenue jumped 15 percent12-02-2024
Aurobindo Pharma Q3 results: Net profit jumps 90% to Rs 936.2 crore
Earlier, Aurobindo Pharma reported an 85 percent year-on-year rise in consolidated net profit to Rs 757 crore in the July-September quarter10-02-2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on Unaudited Financial Results for the third quarter and nine months period ended on 31st December 202310-02-2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation on Unaudited Financial Results for the quarter and nine months period ended on 31st December 202310-02-2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Change in Directorate
Board of Directors in their meeting held today, February 10, 2024, appointed Dr. Deepali Pant Joshi as an Independent Director (subject to approval of shareholders) and accepted the resignation of Dr. Avnit Bimal Singh as an Independent Director.10-02-2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Dividend Updates
Board of Directors in their meeting held today, February 10, 2024, approved the payment of Second Dividend of 150% i.e. Rs.1.50 per shares of Re.1 each.10-02-2024
AUROBINDO PHARMA LTD. - 524804 - Financial Results For The Quarter Ended 31St December 2023
Submission of Financial Results for the quarter and nine months period ended 31st December 202310-02-2024
AUROBINDO PHARMA LTD. - 524804 - Board Meeting Outcome for Intimation Of Outcome Of Board Meeting Held Today, February 10, 2024
Intimation of outcome of Board meeting held on February 10, 202410-02-2024
AUROBINDO PHARMA LTD. - 524804 - Intimation Of Order Passed By Regulatory Authority
Intimation of order received by Aurobindo Pharma USA Inc, a 100% subsidiary of the Company, from New York State Department of Taxation and Finance09-02-2024